Rabinowitz Matthew sold $299K of NTRA
Rabinowitz Matthew (EXECUTIVE CHAIRMAN) sold 748 shares of Natera, Inc. (NTRA) at an average of $400.02 ($388.20–$400.29, $0.30M total) across 2 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Provides fresh, primary‑source data on insider activity for Natera.
Market read
Small insider sale; limited trading relevance.
What to watch
The insider retains over 2 million shares, indicating continued confidence.
Background
Form 4 filing discloses insider transactions required by the SEC.
Ticker impact
Executive Chairman Matthew Rabinowitz sold $299K of NTRA shares via a 10b5‑1 plan on 2026‑11‑02.
likely modest pressure as the market prices in the insider sell
A $299K sale by a top executive signals potential concerns, but the amount is modest relative to total holdings.
Market effects
Minimal impact on the broader biotech sector.
No significant regional effect.
Limited relevance to global markets.
Counterpoint
The sale could be routine portfolio rebalancing, not a negative signal.
Key entities
- companyNatera, Inc.
US‑listed biotech firm (NASDAQ:NTRA).
- personMatthew Rabinowitz
Executive Chairman of Natera.



